Eur Rev Med Pharmacol Sci 2022; 26 (4): 1070-1072DOI: 10.26355/eurrev_202202_28094 Can the cardioprotective effect of microRNA-103 inhibitors be extended to women with polycystic ovary syndrome? P. Ramaswamy, M.K. Sibin, P. Misra, R. Sahu Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (4): 1068-1069DOI: 10.26355/eurrev_202202_28093 Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients–a systematic review A. Caturano, V. Brunelli, R. Galiero, S. Spiezia, L. Rinaldi, F.C. Sasso Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (4): 1065-1067DOI: 10.26355/eurrev_202202_28092 Open vs. closed vitrification system: which one is safer? G. Gullo, A. Perino, G. Cucinella Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (3): 740-742DOI: 10.26355/eurrev_202202_27980 Age, sex, and comorbidities related trajectories of deceased COVID-19 patients in Balochistan, Pakistan M.S. Rana, M. Usman, A. Raisani, M.M. Alam, M. Umair, M. Salman, A. Ikram, S.S. Zahoor Zaidi, K.J. Alzahrani, N. Mehmood Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (3): 736-739DOI: 10.26355/eurrev_202202_27979 Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors M. Fasano, M. Pirozzi, A. Zotta, M. Caterino, S. Facchini, G. Messina, L. Rinaldi Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (3): 734-735DOI: 10.26355/eurrev_202202_27978 Side effects to BNT162b2 can be severe J. Finsterer, F.A. Scorza Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (2): 347-349DOI: 10.26355/eurrev_202201_27858 OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease? A. Di Stadio, E. Bernitsas, M. Ralli, C. Severini, M.J. Brenner, C. Angelini Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (1): 4-5DOI: 10.26355/eurrev_202201_27740 Good nutrition is essential for vaccine efficacy in elderly subjects L. Curtis Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (1): 1-3DOI: 10.26355/eurrev_202201_27739 Parosmia after COVID-19: olfactory training, neuroinflammation and distortions of smell A. Di Stadio, L. D’Ascanio, I. La Mantia, M. Ralli, M.J. Brenner Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7619-7621DOI: 10.26355/eurrev_202112_27607 COVID-19, food supplements and pediatricians. Knowledge of the products and their use: a national survey A. Della Volpe, L. D’Ascanio, A. Di Stadio Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7616-7618DOI: 10.26355/eurrev_202112_27605 Comment on: Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk F. Dell’Annunziata, V. Folliero, C. Zannella, M. Giordano, R. Galiero, M. Galdiero Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (20): 6176-6178DOI: 10.26355/eurrev_202110_26987 Potential role of macrophage activation in mediating thrombotic complications associated with the different vaccines against COVID-19 A. Maccio, C. Madeddu Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (20): 6174-6175DOI: 10.26355/eurrev_202110_26986 Letter to Editor on the paper entitled “Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer” I. Giacomini, V. Quagliariello, E. Ragazzi, M. Montopoli Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (20): 6171-6173DOI: 10.26355/eurrev_202110_26985 Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine H. Dheir, S. Sipahi, G.C. Cakar, S. Yaylaci, T. Hacibekiroglu, O. Karabay Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (20): 6167-6170DOI: 10.26355/eurrev_202110_26984 One gut microbiota, Fusobacterium nucleatum aggravates Neonatal necrotizing enterocolitis by induction of IRF5 expression through lncRNA ENO1-IT1/miR-22-3p axis M. Romeo Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (20): 6164-6166DOI: 10.26355/eurrev_202110_26983 Decellularization and tissue engineering: viable therapeutic prospects for transplant patients and infertility? M.C. Varone, G. Napoletano, F. Negro Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (19): 5887-5888DOI: 10.26355/eurrev_202110_26864 Letter in response to “Polypharmacy is a determinant of hospitalization in Parkinson’s disease” S. Chu, A. Aamar, S. Hale, A. Roxas, D. Redfearn Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (18): 5581-5583DOI: 10.26355/eurrev_202109_26777 Vitamin D insufficiency is very frequent and linked to inflammatory biomarkers in relapsing polychondritis J. Freire de Carvalho, M.F. Vicente Matias, L.M. Carvalho Bastos, R.P. Correia de Araujo Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (18): 5579-5580DOI: 10.26355/eurrev_202109_26776 Letter to editor, in response to paper entitled “Side effects after COVID-19 vaccinations among residents of Poland” O. Nugraha Putra, A.Y. Nur Hidayatullah Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (17): 5328-5328DOI: 10.26355/eurrev_202109_26638 A response to “Changes in undergraduate medical education due to COVID-19: a systematic review” – A medical student perspective S. Ahmed, Z.A. Khan, R. Velurajah, M. Morje Free PDF Download